Introduction {#sec1_1}
============

IMT is a rare lesion that has no predilection of age, gender or race. Still, the majority of cases are found on persons under the age of 40 \[[@B1], [@B2]\]. The physiopathology underlying this disease is still unknown, with the existence of two principal hypothesis \[[@B2]\]. Firth suggests that it is an intensive inflammatory response to an infection. Other hypothesis advocates that there is a relation between the proliferation of immune cells and a lesion of low-grade malignancy. The chromosomal rearrangement found in nearly two-thirds of cases the ALK locus (2p23) supports the uncontrolled response to low-grade tumors. As a final consideration, it is recommended, for treatment, the resection of the tumor, if possible, an association with corticosteroids, chemotherapy or radiotherapy, is also preconized. There are studies undergoing for the use of Crizotinib for IMT with positive ALK rearrangement \[[@B3]\].

Case Report {#sec1_2}
===========

A 37-year-old male patient was evaluated in the Thoracic Surgery Outpatient, Brasília, Brazil after complaining about ventilatory-dependent thoracic pain in the right costal grid, due to a mass that progressively increased in a three-month period. At clinical examination, a painless tumor was observed in the anterior portion of the right hemithorax with an infiltrative and erythematosus pattern. It was also observed facial edema and jugular turgidity, compatible with superior vena cava syndrome. He had smoked for ten years, twenty cigarettes per day. Even though he stopped eight years ago, his mother died from metastatic breast neoplasia when she was 35 years old. Laboratory test results showed the presence of hypergammaglobulinemia, increased production of IgM, IgA and IgG and a higher erythrocyte sedimentation rate. The contrasted chest magnetic resonance evidenced an expansive lesion of infiltrative pattern in the retrosternal region, reaching the soft parts and the intercostal muscles between the first and the fourth right costal cartilages (Fig. [1](#F1){ref-type="fig"}).

Surgical approach of the tumor was performed through a posterolateral thoracotomy. A surgical biopsy was made. The histological description was compatible with IMT without atypical lymphocytes. Histological samples also revealed fusiform cells proliferation, arranged in curved bundles, sometimes in a whirl pattern, between which there was founded an important number of foamy histiocytes, plasmocytes and multinucleate cells (Fig. [2](#F2){ref-type="fig"}).

Considering the impossibility of surgical resection, treatment with corticoids (1 mg of prednisone per kilo) was initiated. After a month of therapy, the patient presented regression of the expansive lesion of the chest. Nevertheless, the facial edema and the Superior vena cava syndrome got worse. New images were made.

The computerized tomography with protons emission - PET/CT-scan - revealed retrosternal expansive lesion, poorly defined and with an heterogeneous metabolism increasing, that extends from the first to the fourth right costal arches and involves the region of the right internal mammary and the right cardiophrenic region, presenting an increased metabolism (SUV = 3, 8) and mediastinal lymphadenomegaly, presenting an increased metabolism in the upper and lower paratracheal region (SUV = 19, 9) (Fig. [1](#F1){ref-type="fig"}).

Considering the advance of the mediastinal lymphadenomegaly and the expansive lesion, the patient was submitted to a mediastinoscopy with an excisional biopsy of several mediastinal lymph nodes, which report revealed: fibrofatty tissue with elongated cells proliferation and no evident atypia related to the collagen deposition and the mixed infiltration of lymphocytes, plasmocytes and frequent eosinophils. There were also observed, in the sample, atypical big lymphocytes, and positive CD30 (Fig. [2](#F2){ref-type="fig"}), following the immunohistochemistry panel (Table [1](#T1){ref-type="table"}), suggesting the hypothesis of the Classical Hodgkin lymphoma, nodular sclerosis subtype.

Considering the hypothesis of two synchronous neoplasias and the fact that some rare variants of the IMT don\'t react to the corticoids, it was made a research for the ALK rearrangement with the FISH method (Fluorescent In Situ Hybridisation). The result was negative for the rearrangement. Therefore, it can be concluded that the HL in Ann Arbor staging 2BX, was coexisting with the IMT. The histopathology strengthens the diagnosis, the morphological presentation of the inflammatory tissue and the atypical lymphocytes were not similar to any LH subtype. It presented a bigger number of fibroblasts than usual and no nodular disposition, as expected. Facing those histological and genetic findings, a therapy with adriamycin, bleomycin, vinblastine, dacarbazine was started, following the ABVD protocol, in four cycles in tandem with the radiotherapy. After treatment, the patient made a PET-scan for control that resulted in the complete resolution of the expansive lesion in the thorax and a mediastinal lymphadenomegaly (Fig. [1](#F1){ref-type="fig"}).

Considering the diagnose off two synchronous neoplasia and of the family history, the patient has been investigated following the short hereditary panel to exclude the main genetic syndromes linked to cancer: BRCA1, BRCA2, NBN.

Finally, as differentiated diagnoses, malign tumors in lung, lung metastasis and sarcoidosis have been considered. However, the clinical investigation described earlier allowed the exclusion of those and the confirmation of a rare case where there can be found an LH synchronous with an IMT.

Results {#sec1_3}
=======

The medical investigation concluded that this case consisted of two synchronous lesions, IMT concomitant with classical HL. The histopathology confirms the diagnosis. The patient had a full response to treatment.

Discussion/Conclusion {#sec1_4}
=====================

IMT is a rare lesion. However, it has been reported in a variety of anatomical sites. It is a non-neoplastic lesion, however, it is clinically an radiologically similar to malignant diseases. In this way, the medical team needs to keep in mind this differential diagnosis. In addition, as highlighted with the literature review, there are few cases where the ITM can occur simultaneously or after a neoplastic disease \[[@B4]\].

ITM can be characterised pathologically, radiologically or in a laboratory. A classical histopathology of ITM is characterised by fusiform organised myofibroblasts - this can be observed in Figure from the biopsy - \[[@B4]\]. Laboratory findings revealed hypergammaglobulinemia, with an increase of immunoglobulins fractions, such as IgM, IgA, IgG, increased hemo sedimentation rate and thrombocytosis. Our patient presented hypergammaglobulinemia and increased hemo sedimentation rate. Depending on the affected anatomical site, IMT can have several presentations, but generally, it is a limited lesion that can present calcification, especially on kids. In some cases, it is necessary to make a computed tomography to eliminate other etiologies. In this case, the tumor mass was not delimited. The atypical morphology can be due to ITM and Hodgkin lymphoma synchrony.

As described, the ITM appeared simultaneously with the Hodgkin lymphoma and in the same anatomic place. The literature review about ITM and malignant diseases was made considering that the ITM was the first one to appear in the anatomic site. It revealed one unique case \[[@B14]\]. Concomitant cases were summarised in Table [2](#T2){ref-type="table"} \[[@B5], [@B6], [@B7], [@B8], [@B9], [@B10], [@B11], [@B12], [@B13], [@B14], [@B15]\]. The anatomical place of the disease has been assessed in cases 1, 3, 4 and 6 - summarised in Table [2](#T2){ref-type="table"}. There can be seen an anatomical proximity between ITM and malignant neoplasia with none corresponding to HL. The only case where an anatomical correlation between ITM and HL existed was case number 10. However, in this case, the IMT was grown after radiation, which means that the IMT was localized in a region once affected by HL, but no concomitantly with this neoplasia.

Our literature review emphasise the correlation between IMT and other malignant diseases, being before, after or during the evolution of the IMT. At the best of our knowledge, no case has been found where IMT was coexisting with HL. It can be said that this case is the first report of a tumor characterized by HL and ITM, without being a complication or relapse from the neoplasia, as mentioned before.
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![**A** - Surgical biopsy demonstrates: fusiform cells proliferation, arranged in curved bundles, sometimes in a whirl pattern, between which there was founded an important number of foamy histiocytes, plasmocytes, and multinucleate cells. **B** - Second biopsy, it is observed, in the sample, atypical big lymphocytes. **C** - Second biopsy, it is observed, in the sample, positive CD30.](cro-0012-0119-g01){#F1}

![**A** - Firth contrasted chest magnetic resonance evidenced an expansive lesion of infiltrative pattern in the retrosternal region, reaching the soft parts and the intercostal muscles between the first and the fourth right costal cartilages. There wasn\'t a cleavage plane between the lesion and the pectorals major muscle. **B** - Computerised tomography with protons emission - PET/CT-scan - revealed retrosternal expansive lesion, poorly defined and with an heterogeneous metabolism increasing, that extends from the first to the fourth right costal arches and involves the region of the right internal mammary and the right cardiophrenic region, presenting an increased metabolism (SUV = 3, 8) and mediastinal lymphadenomegaly, presenting an increased metabolism in the upper and lower paratracheal region (SUV = 19, 9). **C** - Control computerised tomography with protons emission - PET/CT-scan that resulted with the complete resolution of the expansive lesion in the thorax and a mediastinal lymphadenomegaly.](cro-0012-0119-g02){#F2}

###### 

Immunohistochemistry panel

  Antibodies                                                      Clone        Result
  --------------------------------------------------------------- ------------ ----------------------------------------
  Smooth muscle actin                                             1A4          Negative
  CD34 - antigen of haemopoietic progenitor cells and pericytes   QBEnd 10     Negative
  Desmin (intermediary filament of muscular cells)                D33          Negative
  Protein S-110                                                   Polyclonal   Negative
  STAT6                                                           Polyclonal   Negative
  CD246 - protein ALK, translocation product(2;5)                 ALK1         Negative
  Cytokine de 40, 48, 50 e 50.6 kDa                               AE1/AE3      Negative
  CD30 - antigen Ki-1                                             Ber-H2       Positive in atypical lymphocytes cells
  CD15 - antigen of granulocytes and Reed- Sternberg cells        Carb-3       Negative
  Oncoprotein LPM-1 of Epstein-Barr virus                         CS1-4        Negative
  PAX5, Familiar transcription factor - paired box                Polyclonal   Negative

###### 

IMT concomitant cases summarised \[[@B5], [@B6], [@B7], [@B8], [@B9], [@B10], [@B11], [@B12], [@B13], [@B14], [@B15]\]

  *N*   Clinical context                                                                              Age/sex   IMT anatomical location                                                 Linked bibliography
  ----- --------------------------------------------------------------------------------------------- --------- ----------------------------------------------------------------------- ---------------------
  1     Gastric collision tumor formed by GIST e IMT                                                  16/F      Stomach body                                                            5
  2     IMT in bladder coexisting with ovarian teratoma                                               19/F      Bladder                                                                 6
  3     IMT in breast coexisting with breast cancer                                                   39/F      Left breast medial upper quadrant                                       7
  4     Stomatal IMT coexisting with GIS and e hepatic hemangioma                                     80/M      Pre-pyloric                                                             8
  5     Spleen IMT as found during surgery for removing tumor cells B in stomach                      40/M      Spleen                                                                  9
  6     Mediastinal IMT simultaneously with HL                                                        58/M      Superior mediastinum                                                    10
  7     Spleen IMT as found during investigation for HL staging                                       60/M      Spleen                                                                  11
  8     IMT after HL considered cured                                                                 70/F      Abdomen and mediastinum                                                 12
  9     IMT after HL considered cured                                                                 14/F      Lower lobe of the left lung                                             13
  10    IMT formerly affected region with HL                                                          16/M      Left upper lobe of the lung former infected region by HL and radiated   14
  11    Diagnosed Pancreas IMT during chemotherapy support for Lymphoma of uterine cervix treatment   42/F      Pancreas                                                                15
